Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection
W Yu, N Yin, Y Yang, C Xuan, X Liu, W Liu, Z Zhang… - Acta biomaterialia, 2022 - Elsevier
Rational design of nanomedicine to accelerate thrombolysis and sequentially avoid
thrombolysis-mediated reperfusion injury is still a challenge. Here, we develop a biomimetic …
thrombolysis-mediated reperfusion injury is still a challenge. Here, we develop a biomimetic …
Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection.
W Yu, N Yin, Y Yang, C Xuan, X Liu, W Liu… - Acta …, 2021 - europepmc.org
Rational design of nanomedicine to accelerate thrombolysis and sequentially avoid
thrombolysis-mediated reperfusion injury is still a challenge. Here, we develop a biomimetic …
thrombolysis-mediated reperfusion injury is still a challenge. Here, we develop a biomimetic …
Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection
W Yu, N Yin, Y Yang, C Xuan, X Liu… - Acta …, 2022 - pubmed.ncbi.nlm.nih.gov
Rational design of nanomedicine to accelerate thrombolysis and sequentially avoid
thrombolysis-mediated reperfusion injury is still a challenge. Here, we develop a biomimetic …
thrombolysis-mediated reperfusion injury is still a challenge. Here, we develop a biomimetic …
[PDF][PDF] Rescuing Ischemic Stroke by Biomimetic Nanovesicles through Accelerated Thrombolysis and Sequential Ischemia-Reperfusion Protection
W Yu, N Yin, Y Yang, C Xuan, X Liu, W Liu, Z Zhang - researchgate.net
Rational design of nanomedicine to accelerate thrombolysis and sequentially avoid
thrombolysismediated reperfusion injury is still a challenge. Here, we develop a biomimetic …
thrombolysismediated reperfusion injury is still a challenge. Here, we develop a biomimetic …